Cytotoxic Immune Response Blunts Long-Term Transgene Expression after Efficient Retroviral-Mediated Hepatic Gene Transfer in Rat

This publication has 45 references indexed in Scilit:

• CMV-β-Actin Promoter Directs Higher Expression from an Adeno-Associated Viral Vector in the Liver than the Cytomegalovirus or Elongation Factor 1α Promoter and Results in Therapeutic Levels of Human Factor X in Mice
  Human Gene Therapy, 2001
• Persistent, Therapeutically Relevant Levels of Human Granulocyte Colony-Stimulating Factor in Mice after Systemic Delivery of Adeno-Associated Virus Vectors
  Human Gene Therapy, 1999
• High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels ofα₁-Antitrypsin with Negligible Toxicity
  Human Gene Therapy, 1998
• Liver-Directed Gene Transfer Vectors
  Human Gene Therapy, 1998
• An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene
  Proceedings of the National Academy of Sciences, 1998
• Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
  Nature Genetics, 1997
• Adenovirus-Mediated Gene Therapy in a Mouse Model of Hereditary Tyrosinemia Type I
  Human Gene Therapy, 1997
• MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses
  Immunity, 1994
• In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.
  Proceedings of the National Academy of Sciences, 1994
• Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
  Journal of Clinical Investigation, 1993